Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study

• Main Authors: Xue-Sha Zhang (Author), Wen-Ke Cai (Author), Ping Wang (Author), Ran Xu (Author), Sun-Jun Yin (Author), Yan-Hua Huang (Author), Yu Guo (Author), Fang-Fang Jiang (Author), Jian-Mei Pan (Author), Yi-Hua Li (Author), Gong-Hao He (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Our previous study reported that histamine H2 receptor antagonists (H2RAs) exposure was associated with decreased mortality in critically ill patients with heart failure (HF) through the same pharmacological mechanism as β-blockers. However, population-based clinical study directly compa...